Back to search

Ireland· IE-PA-EU/1/15/1078/004

Natpar 100 micrograms/dose powder and solvent for solution for injection

A parathyroid hormone product containing parathyroid hormone (rdna), registered in Ireland by Shire Pharmaceuticals Ireland Limited. The same ATC class is registered in 10 of our 19 countries.

ATC H05AA03

Checked against HPRA (Ireland) on

Informational only — not a medical device.

SOURCE REGISTER · IEHPRA (Ireland)normalisedNatpar 100 micrograms/dose powder and…ATCH05AA03REGISTER NO.IE-PA-EU/1/15/1078/004PACKS LISTED1CHECKEDSeptember 21, 2026

Where it is registered

Parathyroid hormone is registered in 10 of 19 countries.

Countries holding a registration under ATC H05AA03 (parathyroid hormone), each read from that country’s own register.

  • This record: Ireland, from HPRA (Ireland)
  • 6 of them publish a price we can compare per daily dose

Parathyroid hormone · ATC H05AA03

10 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

HPRA (Ireland)
Active substance
Parathyroid hormone (rdna)
Manufacturer
Shire Pharmaceuticals Ireland Limited
Country
Ireland (IE)
ATC code
H05AA03
ATC class
Parathyroid hormone
Defined daily dose
0.1 mg, P
Reimbursed
Not published by this register
Source register
HPRA (Ireland)
Last checked
September 21, 2026

Packs & prices · 1

  • ie_pa_number
    EU/1/15/1078/004

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

5 interactions on record for parathyroid hormone.

Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Parathyroid hormone · interactions on record

5 records

  • 2 severe
  • 3 moderate

Most severe, free to view

  • DigitoxinC01AA04severe
  • DigoxinC01AA05severe
  • CalcipotriolD05AX02moderate
  • CalcitriolD05AX03moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e6a7be4c-c95d-4497-a2a3-75b9c534be4e
GET /v1/drugs/e6a7be4c-c95d-4497-a2a3-75b9c534be4e?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Powder and solvent for solution for injection",
  "routes": [
    "Subcutaneous use"
  ],
  "source": "hpra",
  "atc_all": [
    "H05AA",
    "H05AA03"
  ],
  "strength": null,
  "pa_number": "EU/1/15/1078/004",
  "substances": [
    "Parathyroid hormone (rdna)"
  ],
  "legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
  "market_info": "Unknown",
  "authorised_at": "24/04/2017",
  "dispensing_status": "Product subject to prescription which may not be renewed (A)",
  "registration_status": "AU",
  "supply_legal_status": "Supply through pharmacies only",
  "interchangeable_code": null
}

See everything about parathyroid hormone.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.